Revenue and EBITDA grew modestly in H1 2025, with strong performance in high-end segments and robust cash generation. Guidance for 2025 is confirmed, supported by a favorable product mix, cost controls, and a resilient business model despite market volatility.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.